AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93023C00024SORRENTO THERAPEUTICS, INC.
Overview
Award facts
- Net obligations
- $4.59M
- $4,590,862of $4.59M potential value
- Outlays (paid to date)
- $4.01M
- $4.01M paid of $4.59M obligated$4,011,840
- Period of performance
- Jun 1, 2023 to May 2, 2025
- Ended
- Modifications
- 2
- Latest action Apr 25, 2025
- Contract type
- Definitive contract
- PIID 75N93023C00024
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BAA RESEARCH AREA 004 - "DEVELOPMENT OF IN VITRO FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES"
Dates and value
- Award date
- Signed on Jun 1, 2023
- Potential end of performance
- May 1, 2025
- Current value
- $4,590,862Base and exercised options
- Potential value (if all options are exercised)
- $4,590,862
Obligations by fiscal year of action
- FY2023: $4,590,862
Total across 1 fiscal year: $4,590,862
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 25, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN DIEGO, CA
UEIKWEWLHZ59FL3
CAGE code5SPZ9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySORRENTO THERAPEUTICS, INC.
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- San Diego, California 92121-4746
- Congressional district (place of performance)
- CA-51As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 19
Solicitation and notices
- Solicitation ID
- BAA2022-1(as reported)
- Solicitation date
- Jan 18, 2022
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 1, 2023Base obligation at award: $4,590,862
- Latest action
- Apr 25, 2025 — Terminated for convenienceModification P00002
- Latest substantive action
- Apr 25, 2025 — Terminated for convenienceModification P00002
- Actions by type
- Base award1
- Terminated for convenience1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2024-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- N: Emergency P.L. 116-136
- COVID-19 supplemental obligations
- $4,590,862
- COVID-19 supplemental outlays
- $4,011,840